[1]周 萍,郭 璇,武 倩,等.西安地区更年期女性骨代谢指标预测骨质疏松效果评估[J].现代检验医学杂志,2017,32(02):149-152.[doi:10.3969/j.issn.1671-7414.2017.02.042]
　ZHOU Ping,GUO Xuan,WU Qian,et al.Evaluation of Boned Metabolism Quota in the Prediction of Osteoporosis of Climacteric Female in Xi'an Area[J].Journal of Modern Laboratory Medicine,2017,32(02):149-152.[doi:10.3969/j.issn.1671-7414.2017.02.042]
点击复制

西安地区更年期女性骨代谢指标预测骨质疏松效果评估()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年02期
页码:
149-152
栏目:
检验与临床
出版日期:
2017-03-25

文章信息/Info

Title:
Evaluation of Boned Metabolism Quota in the Prediction of Osteoporosis of Climacteric Female in Xi'an Area
文章编号:
1671-7414(2017)02-149-04
作者:
周 萍; 郭 璇; 武 倩; 胡 健; 王晓琴
西安交通大学第一附属医院检验科,西安 710061
Author(s):
ZHOU Ping; GUO Xuan; WU Qian; HU Jian; WANG Xiao-qin
Department of Clinical Laboratory,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
关键词:
骨质疏松;  25(OH)D;  甲状旁腺激素;  血钙;  血磷;  绝经
分类号:
R591.1; R446.11
DOI:
10.3969/j.issn.1671-7414.2017.02.042
文献标志码:
A
摘要:
目的 探讨西安地区更年期女性的血清维生素D[25(OH)VD]以及骨代谢常用指标甲状旁腺激素(parathyroid hormone,PTH)、血钙(calcium,CA)和血磷(phosphorus,P)与骨密度分级之间的关系。方法 于2016年1月～4月期间收集交通大学第一附属医院门诊常规体检年龄分布于40～60岁更年期健康女性352例,根据骨密度检测结果分为骨密度正常组(T>-1)、骨密度减少组(-2.5<T<-1)和骨密度疏松组(T<-2.5)。采用电化学发光免疫分析法检测入组样本血清中25(OH)VD及PTH,CA和P的水平。采用Kruskal-Wallis检验和卡方检验分析不同骨密度水平组中年龄、血清25(OH)VD,PTH,CA和P的差异。结果 统计分析发现骨密度减少组[2.27(2.20～2.32)mmol/L]和骨密度疏松组[2.27(2.23～2.33)mmol/L]中受试者的血CA显著高于骨密度正常组[2.24(2.18～2.29)mmol/L,Z=9.669,P<0.01]; 骨密度减少组[1.15(1.09～1.23)mmol/L]和骨密度疏松组[1.18(1.09～1.25)mmol/L]中受试者的血P浓度明显高于骨密度正常组[1.11(0.99～1.23)mmol/L),Z=13.64,P<0.01]; 骨密度疏松组受试者的年龄54(50～57)岁,明显高于骨密度减少组51(47～54)岁和骨密度正常组[47(43～50)岁,Z=73.08,P<0.01]; 骨密度疏松组和骨密度减少组的绝经率显著高于骨密度正常组,差异有统计学意义(χ2=13.81,P<0.01); 组间25(OH)VD的水平和PTH水平比较,差异无统计学意义。结论 更年期女性骨密度水平受年龄、绝经与否及血清CA和P水平等因素的影响较大,但没有足够的证据证明血25(OH)VD和PTH的水平影响骨密度水平,因此监测更年期女性的绝经情况、CA和P水平对女性骨质疏松发生的预防和治疗至关重要。
Abstract:
Objective To investigate the relationship amongage,menopausal status,serum 25(OH)VD and skeletal metabolism index as PTH(Parathyroid Hormone),CA(Calcium),P(Phosphorus)and boned mineral density(BMD)of climacteric female in Xi'an.Methods 352 cases of healthy women at the age of 40～60 were collected who did routine examination in outpatient building of the First Affiliated Hospital of Xi'an Jiaotong University from January 2016 to April 2016.According to the results of skeletal densitytest,all subjects were divided into 3 groups as the normal group(T>-1),the reduction group(-2.5<T<-1),the osteoporosis group(T<-2.5).Electrochemiluminescent immunoassay(ECLIA)was used to detect levels of serum 25(OH)VD,PTH,CAand P.Kruskal-Wallis test and chi-square test were used to analyze differences of age,serum 25(OH)VD,PTH,CA and P in different levels of bone mineral density groups.Results Compared with bone density normal group 2.24(2.18～2.29)mmol/L,serum CA levels of bone mineral density reductiongroup 2.27(2.20～2.32)mmol/L and osteoporosis group 2.27(2.23～2.33)mmol/L were significantly higher(Z=9.669,P<0.01).Serum P levels of bone mineral density reduction group 1.15(1.09～1.23)mmol/L and osteoporosis group 1.18(1.09～1.25)mmol/L were obviously higher than bone density normal group,1.11(0.99～1.23)mmol/L(Z=13.64,P<0.01).Ages of osteoporosis group 54(50～57)years and bone mineral density reduction group 51(47～54)years weresignificantly older than Bone density normal group 47(43～50)years(Z=73.08,P<0.01).The rate of menopause in osteoporosis group and bone mineral density reduction group were significantly higher than in bone density normal group(χ2=13.81,P<0.01).There was no statistical difference in serum 25(OH)VD and PTH between groups.Conclusion This study found boned density of climacteric women is more likely correlated with age,menopause status and levels of serum CA and P.There was not enough evidence to prove that25(OH)VD and PTH have effect on skeletal density.Therefore,to monitor and detect the menopause status and levels of serum CA and P of climacteric female is critical for the prevention and treatment on osteoporosis of women.

参考文献/References:

[1] 中华医学会骨质疏松和骨矿盐疾病分会．原发性骨质疏松症治疗指南(2011 )［J］．中华骨质疏松和骨矿盐疾病杂志，2011，4(1)：2-17． Chinese Society of Osteoporosis and Bone Mineral Research．Guideline s for the treatment of primary osteoporosis［J］．Chin J Osteoporosis Bone Miner Res，2011，4(1)：2-17．
[2］ 陶新城，葛 环，杨 玲，等．绝经后妇女膳食平衡指数与骨密度的关系［J］．广 东医学，2015，36(1)：120-122． Tao XC，Ge H，Yang L，et al．Relationship between dietary balance in dex and bone mineral density in postmenopausal women［J］．Guangdong Med J，2015 ，36(1)：120-122．
[3］ Carlos F，Clark P，Galindo-Suárez ＲM，et al．Health care costs of oste openia，osteoporosis and fragility fractures in Mexic［J］．Arch Osteoporos，201 3，8(1/2)：125．
[4］ Dawodu A，Wagner CL．Prevention of vitamin D deficiency in mothers and in fants worldwide-a paradigm shift［J］．Paediatr Int Child Health，2012，32(1)： 3-13．
[5］ Veugelers PJ， Pham TM， Ekwaru JP．Optimal vitamin D supplementation dos es that minimize the risk for both low and high serum 25-hydroxyvitamin D conce ntrations in the general population［J］．Nutrients，2015，7(12)：10189-10208．
[6］ Al-Daghri NM，Yakout S，Al-Shehri E，et al．Inflammatory and bone turno ver markers in relation to PTH and vitamin D status among saudi postmenopausal w omen with and without osteoporosis［J］．Int J Clin Exp Med，2014，7(10)：3528- 3535．
[7］ Garg MK，Tandon N，Marwaha RK．The relationship between serum 25-hydroxy vitamin D，parathormone and bone mineral density in Indian population［J］．Cli n Endocrinol(Oxf)，2014，80(1)：41-46．
[8］ Reid IR， Bollad MJ， Grey A．Effects of vitamin D supplements on bone mi neral density：a systematic review and meta-analysis［J］．Lancet，2014，383(99 12)：146-155．

相似文献/References:

[1]武敏,艾文婷,李小凤,等.补肾健骨胶囊对绝经后骨质疏松患者骨代谢相关指标的影响[J].现代检验医学杂志,2015,30(05):73.[doi:10.3969/j.issn.1671-7414.2015.05.022]
　WU min,AI Wen-ting,LI Xiao-feng,et al.Change of Bone Metabolism in Postmenopausal Osteoporosis Patients Treated with Bushenjiangu Capsule[J].Journal of Modern Laboratory Medicine,2015,30(02):73.[doi:10.3969/j.issn.1671-7414.2015.05.022]
[2]廖　强,王　娟.骨质疏松患者血清25(OH)D，骨膜素、铁蛋白水平及其与骨折发生的相关性分析[J].现代检验医学杂志,2021,36(05):138.[doi:10.3969/j.issn.1671-7414.2021.05.031]
　LIAO Qiang,WANG Juan.Serum Levels of 25(OH)D, Periostin and Ferritin in Patients with Osteoporosisand Their Correlation with Fracture[J].Journal of Modern Laboratory Medicine,2021,36(02):138.[doi:10.3969/j.issn.1671-7414.2021.05.031]

备注/Memo

备注/Memo:

作者简介:周 萍(1975-),女,本科,主管检验师,主要从事临床免疫和肿瘤诊断,E-mail:zhouping xa@163.com。
通讯作者:王晓琴,女,博士,教授,主要从事临床免疫及分子诊断工作,E-mail:wangxiao qinh@hotmail.com。
更新日期/Last Update: 2017-04-10